No. HT942526HRRPFRA · Defense Health Agency Contracting Activity - DHACA
DoW Hearing Restoration Focused Research Award
- Award range
- Not specified
- Expected awards
- ~3
- Application deadline
- Sep 10, 2026 8 days left
- Posted
- May 4, 2026
- Last verified
- 3 days ago
At a glance
AI summaryThis program funds basic through translational research to speed drug discovery and therapy development for hearing restoration after military-related auditory system injury. It can support preclinical studies and clinical research, but not clinical trials. Independent investigators at any academic level, or equivalent, may apply. Funding Level 1 allows up to $400,000 in total costs over 2 years, and Funding Level 2 allows up to $1.2 million over 3 years; the Partnering Principal Investigator option is available at Funding Level 2. A letter of intent is required before the full application, with no geographic or set-aside restrictions stated.
AI-generated summary — verify against the announcement
What it funds
Official description from grants.gov
Summary: The fiscal year 2026 (FY26) Hearing Restoration Research Program (HRRP) Focused Research Award (FRA) supports promising research that accelerates drug discovery and therapeutic development for hearing restoration after military-relevant auditory system injury. The FRA may be used to support preclinical studies and/or clinical research. Research must align with at least one of the FY26 HRRP Focus Areas. The FRA cannot be used to support clinical trials, tinnitus research or vestibular research. Distinctive Features: • The FRA offers two Funding Levels to support research at different stages and the exploration/development of ideas of different maturity levels. • Funding Level 2 includes a Partnering Principal Investigator (PI) Option (PPIO) for two PIs, an Initiating PI and a Partnering PI. • Scored peer review criteria include Research Idea/Rationale, Research Strategy and Feasibility, Impact, and Personnel. • Programmatic review criteria include adherence to the intent of the FRA, contribution to the HRRP portfolio, relative impact, and relevance to military health.
Who can apply
- Unrestricted
Program history
USASpending.govAssistance listing 12.420 · Military Medical Research and Development
Real awards this federal program has made — the whole assistance listing (12.420), not just this notice.
| Fiscal year | Awards | Median award | Middle half |
|---|---|---|---|
| FY 2026 (so far) | 374 | $934,195 | $559,998 – $1,477,811 |
| FY 2025 | 967 | $796,174 | $416,995 – $1,480,602 |
| FY 2024 | 1,097 | — | — |
| FY 2023 | 1,115 | — | — |
| FY 2022 | 1,186 | — | — |
| FY 2021 | 1,023 | — | — |
Dollar figures are based on the 1,000 most recent awards we store, not all 5,762 — award counts are complete.
- THE UNIVERISTY OF TEXAS M.D. ANDERSON CANCER CENTER $19,100,256 · FY 2025
- H. LEE MOFFITT CANCER CENTER AND RESEARCH INSTITUTE HOSPITAL, INC. $18,696,738 · FY 2025
- UNIVERSITY OF KENTUCKY RESEARCH FOUNDATION, THE $10,606,583 · FY 2025
- SLOAN-KETTERING INSTITUTE FOR CANCER RESEARCH $10,500,000 · FY 2026
- UNIVERSITY OF VERMONT & STATE AGRICULTURAL COLLEGE $8,491,997 · FY 2025
Source: USASpending.gov · refreshed Aug 25, 2026